Isaksson M, Persson L M
From the Department of Occupational and Environmental Dermatology, Malmö University Hospital, S-205 02 Malmö, Sweden.
Am J Contact Dermat. 1998 Jun;9(2):136-8.
Contact allergy to corticosteroids is not uncommon. As the clinical pattern that the patients exhibit may be misleading, the discovery at patch testing may be unexpected and solely a result of the fact that marker molecules for corticosteroid contact allergy are incorporated into standard series and that tests are read twice, on D3/4 and D7.
We describe a patient allergic to hydrocortisone who was given a cross-reacting corticosteroid, prednisolone, that led to a systemic contact dermatitis. The patient cleared when betamethasone, a non¿Ncross-reacting corticosteroid, was administered.
The patient was patch tested to a standard series including tixocortol pivalate, and an extended corticosteroid series including betamethasone.
Patch testing with tixocortol pivalate provoked an allergic patch test reaction (+? D3, +D7), whereas betamethasone did not.
Our patient's allergy was undiagnosed for 5 years, and it was not until she was given a cross-reacting corticosteroid, which led to exacerbation of her dermatitis, that her physician suspected corticosteroid allergy. The incorporation of marker molecules for the detection of corticosteroid contact allergy into standard series with two reading occasions, 3 to 4 days apart, is advocated.
对皮质类固醇的接触性过敏并不罕见。由于患者表现出的临床症状可能具有误导性,斑贴试验中的发现可能出乎意料,这仅仅是因为皮质类固醇接触性过敏的标记分子被纳入标准系列,并且试验在第3/4天和第7天进行两次读数。
我们描述了一名对氢化可的松过敏的患者,给予其交叉反应性皮质类固醇泼尼松龙后导致了全身性接触性皮炎。给予非交叉反应性皮质类固醇倍他米松后,患者病情缓解。
对该患者进行了斑贴试验,试验物包括标准系列中的特戊酸替可的松,以及包括倍他米松在内的扩展皮质类固醇系列。
用特戊酸替可的松进行斑贴试验引发了过敏斑贴试验反应(第3天为+,第7天为+),而倍他米松则未引发。
我们的患者的过敏症状5年来一直未被诊断出来,直到给予她一种交叉反应性皮质类固醇导致皮炎加重,她的医生才怀疑是皮质类固醇过敏。提倡将用于检测皮质类固醇接触性过敏的标记分子纳入标准系列,并在间隔3至4天的两个时间点进行读数。